Amar Ahmad

Research Scientist / Biostatistician Affiliation: NYU Abu Dhabi
Education: German Diplom University of Munich (LMU); PhD University of Munich (LMU)

Research Areas: Application of statistics in medical research; Multivariate statistical strategies for data mining; Clinical trial design; Pragmatic clinical trial; Cancer Research

Amar Ahmad was awarded a Ph.D. in Statistics by the University of Munich (Ludwig Maximilian University) in 2007. This follows a German Diplom (equivalent to having earned both U.S. Bachelor's and Master's degrees) in Statistics in 2003 by the University of Munich (Ludwig Maximilian University) in Germany. He is a fellow of the Royal Statistical Society in the UK. He has worked as a biostatistician for the last two decades. Ahmad worked as a research assistant at the University of Munich in 2003. In 2007, He worked on the statistical analysis of clinical trial methodology at Bayer Pharmaceuticals in Berlin-Germany. Ahmad moved to London University in 2009 to work at the Institute of Cancer Research and later in 2010 at Queen Mary University of London. In November 2019, he started working as a Research Scientist at New York University Abu Dhabi in the United Arab Emirates. His publication "Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Ahmad et al. (2015). Br J Cancer" was selected as the paper of the year in Cancer Prevention by The Scottish Cancer Prevention Network. In 2010, Ahmad awarded his colleagues the Jeramy Jass Prize for Research Excellence in Pathology.